Ronald C Renaud Jr Cerevel Therapeutics Holdings, Inc. (CERE) insider trading activity

CERE Quotes by TradingView

Ronald C Renaud Jr Transaction History

Date Transaction Value Shares Traded Form
Aug 01 2024
SELL
Sale (or disposition) back to the issuer
-
83,857
Aug 03 2023
BUY
Open market or private purchase
$2,009,213 $23.96 p/Share
83,857

Also insider at

TBIO
Translate Bio, Inc. Healthcare
Chief Executive Officer
ATRA
Atara Biotherapeutics, Inc. Healthcare
IKNA
Ikena Oncology, Inc. Healthcare
Director
UPB
Upstream Bio, Inc.
RCR

Ronald C Renaud Jr

President & CEO
Southn San Francisco, CA

Track Institutional and Insider Activities on CERE

Follow Cerevel Therapeutics Holdings, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CERE shares.

Notify only if

Insider Trading

Get notified when an Cerevel Therapeutics Holdings, Inc. insider buys or sells CERE shares.

Notify only if

News

Receive news related to Cerevel Therapeutics Holdings, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CERE